Final Rules Broaden Pool for Stem Cell Research

...d a boost in January when the U.S. Food and Drug Administration approved the first-ever human trial using embryonic stem cells as a medical treatment. geron Corp., a California-based biotech company, was given permission to implant embryonic stem cells in eight to 10 paraplegic patients who can use their a...

Alliance for Regenerative Medicine Launches

...immense clinical value of these important technologies." "Regenerative medicine holds enormous promise," said Thomas Okarma, President and CEO of geron Corporation. "It is critical to educate policy makers about this technology in order to gain the Federal support necessary to turn that potential into...

NIH May Ease Some, But Not All, Stem Cell Restrictions

...ig boost in January, when the U.S. Food and Drug Administration approved the first-ever human trial using embryonic stem cells as a medical treatment. geron Corp., a California-based biotech company, was given the OK to implant embryonic stem cells in eight to 10 paraplegic patients who can use their arms ...

Stem Cell Biotherapy Sues Casey Nabavi, Co-Founder and Former President, for Conduct Resulting in Claims by SCB Patients Against Nabavi, Embezzling Money and Converting Other Assets Belonging to SCB and for Wrongfully Establishing Cellulogix Biosciences t

... also offers age rejuvenation programs for persons seeking to reverse the effects of aging. The U.S. FDA recently announced that it was approving geron Corporation to engage in a clinical trial with embryonic stem cells to treat spinal cord injuries; and the Obama Administration recently reversed the ...

Obama Lifts Ban on Stem Cell Research

...irst-ever human trial using embryonic stem cells as a medical treatment. geron Corp., a California-based biotech company, was given the OK to implant embr... from human embryos. The stem cells being used in the recently approved geron trial were obtained from one of the Bush administration's approved stem cel...

Obama to End Stem Cell Ban Monday

...rst-ever human trial using embryonic stem cells as a medical treatment. geron Corp., a California-based biotech company, was given the OK to implant embr... from human embryos. The stem cells being used in the recently approved geron trial were obtained from one of the Bush administration's approved stem cel...

BullMarket.com Examines Stem Cell Stocks

... investment newsletter focused on long-term growth and income-generating stocks, has provided subscribers with coverage of stem cell stocks, including geron (Nasdaq: GERN ), Osiris Therapeutics (Nasdaq: OSIR ), Cytori Therapeutics (Nasdaq: CYTX ), and StemCells (Nasdaq: STEM ). All paid and tr...

Scientists Heartened at Prospect of End to Stem Cell Ban

...g embryonic stem cells as a medical treatment. geron Corp., a California-based biotech company, was giv...The stem cells being used in the recently approved geron trial were obtained from one of the Bush administr...e in patients in spite of that recent approval for geron is really very questionable because of the potenti...

UCI behind world's first embryonic stem cell study in humans

... Center, for a clinical trial in patients with acute spinal cord injury. geron Corp. of Menlo Park, Calif., will conduct the clinical trial. "This tria...al cord damage and be willing to receive injections 7-14 days after injury. geron has selected up to seven U.S. medical centers that may participate in the s...

FDA OKs 1st Embryonic Stem Cell Trial

...roved by the U.S. Food and Drug Administration. geron Corp., a California-based biotech company, has bee...sin, in groundbreaking research that was funded by geron Corp. geron is also working on using embryonic stem cells to t...

Geron in Medical Technology

Telomerase Presentations at the AACR 2007 Annual Meeting

...al cancer target for drug and vaccine development. geron holds key intellectual property in the field and l...e been shown to be as active against myeloma CSCs. geron is currently planning a trial with GRN163L in myel...myelogenous leukemia (AML), in the months ahead. geron is developing first-in-class biopharmaceuticals fo...

Research Indicates Geron's Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System

...t attack by the human immune system. Presented by geron scientist Ross Okamura at the Federation of Clinic...r pending the outcome of ongoing safety studies. geron is developing first-in-class biopharmaceuticals fo... for the quarter ended March 31, 2007. Contact geron David L. Greenwood, 650-473-7765 Chief Financial...

Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits

... at Sierra Sciences Lab who, while Director of Molecular Biology at geron Corporation was one of the principal discoverers of the telomerase ... 12 month "PATTON PROTOCOL." TA-65 is sold under exclusive license from the geron Corporation, the recognized worldwide leader in Telomere Biology. CONTACT...

Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for Heart Failure

...alia. The presentation was one of seven involving geron scientists and collaborators that documented the c...rator's laboratories at the University of Alberta. geron remains at the forefront of taking embryonic stem ...our product-based business model. The model is for geron to provide cell-based therapies as off-the-shelf p...

Geron in Biological News

Director of Berman Institute comments on FDA Approval of first human embryonic stem cell trial

...ll be approached to be these human subjects. A good place to start would be by NOT referring to this study as a trial of a stem cell-based therapy, as geron has described it, but rather as a stem cell-based intervention whose therapeutic benefits in humans has not yet been studied. It is also important to...

New York Stem Cell Foundation announces third annual Translational Stem Cell Research Conference

...hael A. Rudnicki, PhD, FRSC, Director, Sprott Centre for Stem Cell Research, Ottawa Health Research Institute; Tom Okarma, MD, PhD, President and CEO, geron Corp.; Amy Wagers, PhD, Assistant Professor of Stem Cell and Regenerative Biology, Joslin Diabetes Center, Harvard University and HSCI; and Owen N. Wi...

UCI awarded $27.2 million for new stem cell building

...likely will be based on work performed in Keirsteads lab at UCI. The therapy will treat people with spinal cord injuries, and the trial will be run by geron Corp. UCI plans to recruit six faculty members to expand its stem cell research and regenerative medicine programs. Along with other campus resou...

Geron Demonstrates hESC-derived cardiomyocytes improve heart function after myocardial infarction

... MENLO PARK, Calif., Aug. 27, 2007 geron Corporation (Nasdaq: GERN) today reported its scie...eness of a scalable production system that enables geron to manufacture the cardiomyocytes for use in ongoi...ne of the most important publications on hESCs for geron to date, said Thomas B. Okarma, Ph.D., M.D., Geron...

Human derived stem cells can repair rat hearts damaged by heart attack

...g cause of death in most of the world. The study was conducted by researchers at the University of Washington School of Medicine in Seattle and at geron Corp. in Menlo Park, Calif. The scientists set out to tackle two of the main challenges to treating damaged hearts with stem cells: the creation of ca...

Stem cell treatment improves mobility after spinal cord injury

... and Kelly Sharp also participated in the study, which was supported by the geron Corp., a UC Discovery grant, Research for Cure, the Roman Reed Spinal Cord ...of California and individual donations to the Reeve-Irvine Research Center. geron provides the human embryonic stem cells for Keirstead's research. ...

Two chemicals boost immune cells' ability to fight HIV without gene therapy

... The research was supported by a grant from the National Institute of Allergy and Infectious Diseases and a University of California Discovery Grant. geron provided additional funding and the chemical compounds for use in the laboratory. Effros' team included doctoral student Steven Fauce; Beth Jamieso...

Geron in Biological Technology

MultiVu Video Feed: Geron Receives FDA Clearance to Begin World's First Human Clinical Trial of Embryonic Stem Cell-Based Therapy

Geron to Study GRNOPC1 in Patients with Acute Spinal Cord Injury Geron Corporation (Nasdaq: GERN ) announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company's Investigational New Drug (IND) application for the clinical trial of GRNOPC1 in patient...

2009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60% Despite Current Recession

...ation, GPC Biotech, Theravance, Bionumerik Pharmaceuticals, Anthera Pharmaceuticals, Palatin Technologies, Magen Biosciences, Inspire Pharmaceuticals, geron Pharmaceuticals, Phenomix Corporation and CoNCERT Pharmaceuticals. The show will take place at the beachfront Ocean Place Resort in Long Branch, ...

Repair Stem Cell Institute Weighs in on Reversal of Embryonic Stem Cell Policy

...ls. Sixth, economics: there is no way anyone can make money from the disaster known as embryonics. Just ask those who tried to cash in on the geron hype a few weeks ago." If a loved one suffers from something "incurable," check out our list of highly-honored doctors and the 100+...

iZumi Bio, Inc., Appoints John Walker as Chief Executive Officer

... Company. His many board experiences have included serving as Chairman of Signal Pharmaceuticals and Microcide Pharmaceuticals Inc., and a director of geron Corporation, Discovery Partners Inc., and several other private companies. "We are very pleased to have John joining iZumi Bio as CEO," explain...

Christopher and Dana Reeve Foundation Response to FDA Clearance of Geron's Clinical Trial

...ment today in response to FDA clearance of Geron's human clinical trial of embryonic stem cell-based therapy: "This is an exciting first step for geron and for spinal cord injured patients whose lives may improve due to advances in medical research. There has been so much speculative and unsubstantiat...

Coalition for the Advancement of Medical Research Releases New White Paper, 'Catalyst for Cures: Embryonic Stem Cell Research'

...te paper: Melissa K. Carpenter , Ph.D., former Vice President of Research and Development at Novocell Inc., and Director of Stem Cell Biology at geron Corporation; George Daley , M.D., Ph.D., Harvard Medical School ; Kevin C. Eggan , Ph.D., Principal Faculty, Harvard Stem Cell Institute; John P. ...

Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...CHEM INC. (NYSE: ENZ ) ENZON PHARMACEUTICALS INC. (NASDAQ: ENZN ) EXPRESS SCRIPTS INC. (NASDAQ: ESRX ) FLAMEL TECHNOLOGIES-ADR (NASDAQ: FLML ) geron CORP (NASDAQ: GERN ) HEALTH NET INC. (NYSE: HNT ) ILLUMINA INC. (NASDAQ: ILMN ) INCYTE CORP. (NASDAQ: INCY ) INTEGRA LIFESCIENCES HOLDINGS COR...

Start Licensing, Inc. Welcomes FDA's Finding of Safety of Food From Cloned Animals

...Newswire-USNewswire/ -- Start Licensing, Inc. ("Start"), a joint venture of geron Corporation (Nasdaq:) and Exeter Life Sciences supports the final risk asse...h traits, in their herds." Created in 2005, Start is a joint venture of geron Corporation (Nasdaq: GERN) and Exeter Life Sciences, Inc. Start manages and...